SynCardia’s artificial heart Companion Driver reaches Europe
This article was originally published in Clinica
Executive Summary
SynCardia Systems has CE marked the Companion Driver system for sale in Europe. The device powers the company's total artificial heart, used as a temporary substitute for a heart transplant in patients with end-stage biventricular failure.